Optimization of formulation for enhanced intranasal delivery of insulin with translationally controlled tumor protein-derived protein transduction domain

Intranasal delivery of insulin is an alternative approach to treat diabetes, as it enables higher patient compliance than conventional therapy with subcutaneously injected insulin. However, the use of intranasal delivery of insulin is limited for insulin’s hydrophilicity and vulnerability to enzymat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Hae-Duck, Lee, Ji-Sun, Pyun, Haejun, Kim, Moonhee, Lee, Kyunglim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586149/
https://www.ncbi.nlm.nih.gov/pubmed/31210056
http://dx.doi.org/10.1080/10717544.2019.1628119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586149/
https://www.ncbi.nlm.nih.gov/pubmed/31210056
http://dx.doi.org/10.1080/10717544.2019.1628119

Ejemplares similares